Canterbury Health Laboratories wishes to advise that, as they continue their phased introduction of the new Molecular Platform, the Alinity M, there will be changes over the coming weeks to viral load testing of blood borne viruses.
Canterbury Health Laboratories wishes to advise that, as they continue their phased introduction of the new Molecular Platform, the Alinity M, there will be changes over the coming weeks to viral load testing of blood borne viruses.